Role of Dafflon (Diosmin) in Hemorrhoid Treatment
Dafflon (diosmin) is recommended as an effective first-line treatment for hemorrhoids, reducing symptoms such as pain, bleeding, swelling, and itching, with resolution time of acute flares shortened from 8 days to 4-5 days compared to standard care. 1, 2
Mechanism and Efficacy
Dafflon (diosmin) is a phlebotonic agent that:
- Improves venous tone
- Reduces inflammation and edema
- Strengthens capillary walls
- Improves lymphatic drainage
Clinical evidence demonstrates that diosmin provides:
- Significant reduction in hemorrhoidal symptoms (pain, heaviness, bleeding, pruritus, and anal discharge) 3
- Improved proctoscopic appearance of hemorrhoids 3
- Quicker resolution of acute hemorrhoidal episodes (4-5 days vs 8 days with standard care) 2
- Decreased severity and duration of hemorrhoidal attacks 4, 5
Dosage Recommendations
For acute hemorrhoidal episodes:
- Initial dosage: 3 tablets (450mg each) twice daily for 4 days
- Maintenance: 2 tablets twice daily for 3 days 5
For ongoing management:
- 2 tablets (450mg each) twice daily for the first 7 days
- Then 1 tablet twice daily for up to 2 months 6
Place in Treatment Algorithm
First-degree hemorrhoids (bleed but don't protrude):
- First line: Conservative measures (fiber, hydration) plus diosmin
- Second line: Consider office procedures if symptoms persist
Second-degree hemorrhoids (protrude but reduce spontaneously):
- First line: Conservative measures plus diosmin
- Second line: Office procedures (rubber band ligation preferred)
Third/fourth-degree hemorrhoids:
- Diosmin can be used as adjunctive therapy
- Primary treatment typically requires procedural intervention (rubber band ligation or surgery)
Acute hemorrhoidal episodes:
Evidence Strength and Comparative Efficacy
Multiple clinical trials support diosmin's efficacy:
- A double-blind, placebo-controlled study (n=120) showed statistically significant improvement in pain, pruritus, discharge, edema, erythema, and bleeding 2
- A multi-center observational study (n=268) demonstrated significant improvement in all hemorrhoidal symptoms and proctoscopic appearance 3
- Another double-blind, placebo-controlled trial showed reduced frequency (40% vs 70%), duration (2.6 vs 4.6 days), and severity of hemorrhoidal attacks compared to placebo 4
Clinical Considerations and Caveats
- Safety profile: Excellent tolerability with minimal side effects 6
- Combination therapy: Can be combined with infrared photocoagulation (IRP) for enhanced efficacy, particularly in grade I and II hemorrhoids 2
- Limitations: Less effective for grade III hemorrhoids when used alone 2
- Drug interactions: May affect metabolism of certain medications through CYP450 enzyme system, particularly those metabolized by CYP2E1 and CYP2C9 2
Integration with Other Treatments
Diosmin works best as part of a comprehensive approach:
- Should be combined with high-fiber diet (25-30g daily) and increased water intake (8-10 glasses daily) 1
- Can complement topical treatments for perianal skin irritation
- May reduce the need for analgesics and topical medications 5
- Can be used before or after procedural interventions
Diosmin represents a valuable option in hemorrhoid management, particularly for early-grade hemorrhoids and acute episodes, with strong evidence supporting its efficacy and excellent safety profile.